DK0450021T3 - Anti-cancerforbindelser - Google Patents

Anti-cancerforbindelser

Info

Publication number
DK0450021T3
DK0450021T3 DK90915322.3T DK90915322T DK0450021T3 DK 0450021 T3 DK0450021 T3 DK 0450021T3 DK 90915322 T DK90915322 T DK 90915322T DK 0450021 T3 DK0450021 T3 DK 0450021T3
Authority
DK
Denmark
Prior art keywords
group
pct
hydroxy
nhr
sec
Prior art date
Application number
DK90915322.3T
Other languages
Danish (da)
English (en)
Inventor
Laurence Hylton Patterson
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Application granted granted Critical
Publication of DK0450021T3 publication Critical patent/DK0450021T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
    • C07C291/04—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds containing amino-oxide bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B1/00—Dyes with anthracene nucleus not condensed with any other ring
    • C09B1/50—Amino-hydroxy-anthraquinones; Ethers and esters thereof
    • C09B1/51—N-substituted amino-hydroxy anthraquinone
    • C09B1/515—N-alkyl, N-aralkyl or N-cycloalkyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/24—Anthracenes; Hydrogenated anthracenes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK90915322.3T 1989-10-13 1990-10-12 Anti-cancerforbindelser DK0450021T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898923075A GB8923075D0 (en) 1989-10-13 1989-10-13 Anti-cancer compounds

Publications (1)

Publication Number Publication Date
DK0450021T3 true DK0450021T3 (da) 1994-03-07

Family

ID=10664506

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90915322.3T DK0450021T3 (da) 1989-10-13 1990-10-12 Anti-cancerforbindelser

Country Status (14)

Country Link
US (1) US5132327A (fr)
EP (1) EP0450021B1 (fr)
JP (1) JP2854971B2 (fr)
AT (1) ATE101181T1 (fr)
AU (1) AU634125B2 (fr)
CA (1) CA2038934C (fr)
DE (1) DE69006482T2 (fr)
DK (1) DK0450021T3 (fr)
ES (1) ES2062558T3 (fr)
GB (2) GB8923075D0 (fr)
NZ (1) NZ235658A (fr)
PT (1) PT95584B (fr)
WO (1) WO1991005824A1 (fr)
ZA (1) ZA908178B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141957A (en) * 1990-11-02 1992-08-25 Sphinx Pharmaceuticals Corporation 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
GB9107852D0 (en) * 1991-04-12 1991-05-29 Patterson Laurence H Anti-cancer compounds
GB9107843D0 (en) * 1991-04-12 1991-05-29 Patterson Laurence H Anti-cancer compounds
GB9813062D0 (en) * 1998-06-18 1998-08-19 Univ Wales Medicine An anthraquinone and its derivatives
GB9815910D0 (en) * 1998-07-21 1998-09-23 Btg Int Ltd Synthetic method
FR2786484B1 (fr) * 1998-11-30 2001-01-05 Oreal Aminoanthraquinones cationiques, leur utilisation pour la teinture des fibres keratiniques, compositions tinctoriales les renfermant et procedes de teinture
GB9828670D0 (en) * 1998-12-24 1999-02-17 Univ Montfort Anthraquinone anticancer drugs
GB0112868D0 (en) * 2001-05-25 2001-07-18 Secr Defence Detection system
US7074835B2 (en) * 2002-03-15 2006-07-11 Btg International Limited Formulations of anthraquinone derivatives
GB0223563D0 (en) * 2002-10-10 2002-11-20 Secr Defence Detection system
US6949557B2 (en) * 2003-04-29 2005-09-27 Dabur Research Foundation Hydroanthracene based compounds as anticancer agents
US20050009924A1 (en) * 2003-07-08 2005-01-13 Hsu-Shan Huang Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives
US20070027136A1 (en) * 2003-09-17 2007-02-01 Halbert Gavin W Formulations of anthraquinone derivatives
WO2005061453A1 (fr) * 2003-12-23 2005-07-07 Somanta Limited Utilisation de composes d'anthraquinone en tant que composes anticancereux
CA2556329A1 (fr) * 2004-02-13 2005-09-01 Kudos Pharmaceuticals Limited Procede de preparation de aq4n
US20050222190A1 (en) * 2004-03-30 2005-10-06 Curd John G 1,4-bis-N-oxide azaanthracenediones and the use thereof
US20070117784A1 (en) * 2005-03-04 2007-05-24 Novacea, Inc. Treatment of hyperproliferative diseases with anthraquinones
EP1853243A2 (fr) * 2005-03-04 2007-11-14 Novacea, Inc. Traitement des maladies hyperproliferatives a l'aide d'anthraquinones
WO2008103320A1 (fr) * 2007-02-16 2008-08-28 Novacea, Inc. Méthodes de traitement de troubles ophtalmiques utilisant des anthraquinones
EP2362890B1 (fr) * 2008-10-27 2014-07-16 Life Technologies Corporation Composes a base d'anthraquinone emettant un infrarouge proche et utilisations associees
GB201005939D0 (en) 2010-04-09 2010-05-26 Biostatus Ltd Method of analysing a cell or other biological material containing nucleic acid
GB201214169D0 (en) * 2012-08-08 2012-09-19 Biostatus Ltd New compounds and uses thereof
WO2014062856A1 (fr) 2012-10-16 2014-04-24 Halozyme, Inc. Hypoxie et hyaluronane et leurs marqueurs pour le diagnostic et la surveillance de maladies et de pathologies, et méthodes associées
US9272981B1 (en) * 2015-06-23 2016-03-01 Amazon Technologies, Inc. Method of preparing a compound
US11292803B2 (en) 2018-08-21 2022-04-05 The Board Of Trustees Of The University Of Illinois Bioreducible N-oxide-based probes for imaging of hypoxia

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE194218C (fr) *
US3174994A (en) * 1962-01-30 1965-03-23 Smith Kline French Lab Hypocholesterolemic n-oxide compositions
ZA774443B (en) * 1977-07-22 1978-06-28 Allied Chem Anthrquinone compounds as anti-cancer agents
US4430501A (en) * 1979-08-02 1984-02-07 American Cyanamid Company 1,4-Bis(substituted-amino)-5,8-dihydroxy-anthraquinones and leuco bases thereof
US4540519A (en) * 1977-08-15 1985-09-10 American Cyanamid Company 1,4-Bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof
US4197249A (en) * 1977-08-15 1980-04-08 American Cyanamid Company 1,4-Bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof
US4138415A (en) * 1978-05-05 1979-02-06 American Cyanamid Company 1,4-Bis(aminoalkylamino)-anthraquinones and leuco derivatives thereof
US4820738A (en) * 1977-08-15 1989-04-11 American Cyanamid Company 1,4-bis(substituted-amino)-5,8-dihydroxy-anthraquinones and leuco bases thereof
US4278689A (en) * 1978-07-11 1981-07-14 American Cyanamid Company 1,4-Bis(substituted-amino)-5,8-dihydroxy-anthraquinones and leuco bases thereof
US4526989A (en) * 1978-07-11 1985-07-02 American Cyanamid Company 1,4-Bis (substituted-amino)-5,8-dihydroxy-anthraquinones and leuco bases thereof
US4614618A (en) * 1979-08-02 1986-09-30 American Cyanamid Company 1,4-bis(substituted-amino)-5,8-dihydroxy anthraquinones and leuco bases thereof
US4275010A (en) * 1979-10-24 1981-06-23 American Cyanamid Company 5,8-Dihydroxy-1,4-bis(guanidinylamino)anthraquinones
US4278605A (en) * 1980-06-30 1981-07-14 American Cyanamid Company Heteroalkylenebisanthraquinones
US4555572A (en) * 1983-07-19 1985-11-26 Warner-Lambert Company Pyrazolo[3,4,5-kl]acridine compositions and methods for their production and use
US4626540A (en) * 1983-11-08 1986-12-02 Warner-Lambert Company Substituted 1-amino-4-nitro-acridinones and methods of treating bacterial infections and leukemia with them
US4686218A (en) * 1985-01-30 1987-08-11 Smithkline Beckman Corporation Use of 6-chloro-3-methyl-1H-2,3,4,5-tetrahydro-3-benzazepine-n-oxide, as a prodrug
US4963554A (en) * 1990-02-14 1990-10-16 Ortho Pharmaceutical Corporation 6,7-dimethoxy-1,2-dihydro-2-arylquinazoline-3-oxides

Also Published As

Publication number Publication date
GB2237283B (en) 1993-01-27
US5132327A (en) 1992-07-21
AU6539590A (en) 1991-05-16
ATE101181T1 (de) 1994-02-15
ES2062558T3 (es) 1994-12-16
EP0450021B1 (fr) 1994-02-02
GB8923075D0 (en) 1989-11-29
JPH04502166A (ja) 1992-04-16
EP0450021A1 (fr) 1991-10-09
GB9022217D0 (en) 1990-11-28
AU634125B2 (en) 1993-02-11
DE69006482T2 (de) 1994-05-11
CA2038934C (fr) 2002-11-19
CA2038934A1 (fr) 1991-04-14
NZ235658A (en) 1992-12-23
PT95584A (pt) 1991-09-13
GB2237283A (en) 1991-05-01
WO1991005824A1 (fr) 1991-05-02
DE69006482D1 (de) 1994-03-17
ZA908178B (en) 1992-06-24
PT95584B (pt) 1997-08-29
JP2854971B2 (ja) 1999-02-10

Similar Documents

Publication Publication Date Title
DK0450021T3 (da) Anti-cancerforbindelser
MY108261A (en) Water soluble camptothecin derivatives
DE69213216T2 (de) Quarternäre panthenolderivate und ihre verwendung
LU90988I2 (fr) Ebixa-mémantine e ses dérivés pharmaceutiquement acceptables
PT87147A (pt) Procede de preparation des nouveaux derives de l:amino tetrahydro-5,6,7,8 naphto ]2,3b" furanne
DK0572635T3 (da) Hidtil ukendte forbindelser med guanidinstruktur og farmaceutisk komposition indeholdende forbindelserne
YU48136B (sh) Morfolinil derivati doksorubicina i postupak za njihovo dobijanje
ES2072536T3 (es) Derivados de tiazolidina que presentan actividad anti-hipertensiva y su uso en terapeutica.
GB2254613B (en) Anti-cancer anthracene compounds
ES2075429T3 (es) Derivados de 4,5-cicloalcano-3-benzazepin-7-ol y sus usos.
ATE83776T1 (de) 1,2-benzisoxazole und 1,2-benzisothiazole.
SE8304545D0 (sv) Benzamide derivatives
IT1272881B (it) Composti arilalchilenici